Clinical evaluation of a rubella passive
β
James M. Kilgore
π
Article
π
1979
π
John Wiley and Sons
π
English
β 439 KB
A recently marketed passive hemagglutination (PHA) test (Rubacell, Abbott Laboratories) was compared to the hemagglutination inhibition (HI) test for the detection of antibody to rubella virus. The performance of the PHA system in determining immunity to rubella was evaluated by comparing the PHA re